Experimental rat models of chronic allograft nephropathy: A review

International Journal of Nephrology and Renovascular Disease

Volumn 7, Issue , 2014, Pages 315-322

  Shrestha, Badri ^a   Haylor, John ^a  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Interventions; Late allograft loss; Renal transplantation; Therapy

Indexed keywords

1 [5 CHLORO 2 [2 [4 (4 FLUOROBENZYL) 2 METHYL 1 PIPERAZINYL] 2 OXOETHOXY]PHENYL]UREA; ALLOANTIBODY; CD28 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; CHEMOKINE RECEPTOR CX3CR1; CYCLOSPORIN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EVEROLIMUS; FADROZOLE; FRACTALKINE; IMATINIB; LOSARTAN; MANITIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PRAVASTATIN; RANTES; RAPAMYCIN; SPIRONOLACTONE; TACROLIMUS; TRANDOLAPRIL;

ACUTE GRAFT REJECTION; ANTIGEN PRESENTING CELL; BROWN NORWAY RAT; CELLULAR IMMUNITY; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC GRAFT REJECTION; DARK AGOUTI RAT; DONOR; FISCHER/BROWN NORWAY RAT; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LEWIS RAT; NONHUMAN; OVERALL SURVIVAL; OXIDATIVE STRESS; PATHOGENESIS; RAT MODEL; REVIEW; SPRAGUE DAWLEY RAT; T LYMPHOCYTE ACTIVATION; WISTAR FURTH RAT;

EID: 84905020659     PISSN: None     EISSN: 11787058     Source Type: Journal    
DOI: 10.2147/IJNRD.S65604     Document Type: Review

References (78)

1. Timsit MO, Yuan X, Floerchinger B, Ge X, Tullius SG. Consequences of transplant quality on chronic allograft nephropathy. Kidney Int Suppl. 2010;(119):S54-S58.
2. Erickson L, Wynn C, Pan F, et al. Microarray gene expression profiling of chronic allograft nephropathy in the rat kidney transplant model. Transpl Immunol. 2012;27(2-3):75-82.
3. Luo L, Sun Z, Luo G. Rapamycin is less fibrogenic than cyclosporin A as demonstrated in a rat model of chronic allograft nephropathy. J Surg Res. 2013;179(1):e255-e263.
4. Huang G, Wilson NA, Reese SR, Jacobson LM, Zhong W, Djamali A. Characterization of transfusion-elicited acute antibody-mediated rejection in a rat model of kidney transplantation. Am J Transplant. 2014;14(5):1061-1072.
5. Golby M, White HJ. The operation of orthotopic renal allografting in the pig and its complications. Br J Surg. 1971;58(4):287-288.
6. Collins DL, Christensen RM. Kidney transplantation in the dog: surgical technique. Can J Surg. 1966;9(3):308-315.
7. Mazzaferro V, Makowka L, Enrichens F, et al. A modif ied technique of orthotopic transplant of the kidney in rabbits. J Invest Surg. 1989;2(3):293-303.
8. Fisher B, Lee S. Microvascular surgical techniques in research, with special reference to renal transplantation in rat. Surgery. 1965;58(5): 904-914.
9. Han WR, Murray-Segal LJ, Mottram PL. Modified technique for kidney transplantation in mice. Microsurgery. 1999;19(6):272-274.
10. Daniller A, Buchholz R, Chase RA. Renal transplantation in rats with the use of microsurgical techniques: a new method. Surgery. 1968;63(6):956-961.
11. Denecke C, Reutzel-Selke A, Sawitzki B, et al. Low-dose cyclosporine mediates donor hyporesponsiveness in a fully mismatched rat kidney transplant model. Transplant Immunol. 2012;26(4): 176-185.
12. Lee S. An improved technique of renal transplantation in the rat. Surgery. 1967;61(5):771-773.
13. Frodin L. Renal transplantation in the rat. II. In vitro perfusion of rat kidneys before transplantation. Scand J Clin Lab Invest. 1975;35(5): 455-462.
14. Norlen BJ, Engberg A, Kallskog O, Wolgast M. Nephron function of the transplanted rat kidney. Kidney Int. 1978;14(1):10-20.
15. Oesterwitz H. Orthotopic kidney transplantation in the rat with splintless end-to-end anastomosis of the ureter. Z Urol Nephrol. 1982;75(6):377-386. German.
16. Churchill M, Kline R, Schwartz M, Bidani A, Churchill P. Kidney transplants in cyclosporine-treated Sprague-Dawley rats. Transplantation 1990;49(1):8-13.
17. Lopez-Neblina F, Toledo-Pereyra LH, Suzuki S. Ultrarapid orthotopic technique for renal transplantation in the rat. Microsurgery. 1994;15(4):274-278.
18. Lauritzen CG. The sleeve anastomosis revisited. Ann Plast Surg. 1984;13(2):145-149.
19. Innocenti P, Bonetti G, Cotellese R, Gargano E, Materazzo D, Piattelli A. Transplantation of the kidney in the rat. I. Problems of surgical technic. Boll Soc Ital Biol Sper. 1979;55(20):2070-2075. Italian.
20. Bramis JP, Sloane CE, Schanzer H, Burrows L, Taub RN. Microsurgical renal transplantation techniques in small animals. Invest Urol. 1977;15(2):143-146.
21. Yin M, Booster MH, vd Bogaard AE, Kootstra G. A simple technique to harvest two kidneys from one donor rat for transplantation. Lab Anim. 1994;28(4):387-390.
22. D'Silva M, Gittes RF, Wolf P, et al. Rat kidney transplantation update with special reference to vesical calculi. Microsurgery. 1990;11(2): 169-176.
23. Soots A, Lautenschlager I, Krogerus L, Saarinen O, Ahonen J. An experimental model of chronic renal allograft rejection in the rat using triple drug immunosuppression. Transplantation. 1998;65(1): 42-46.
24. Diamond JR, Tilney NL, Frye J, et al. Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection. Transplantation. 1992;54(4):710-716.
25. Wang M, Liu S, Ouyang N, Song E, Lutz J, Heemann U. Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration. Kidney Int. 2004;66(3):1248-1256.
26. Heidenhain C, Reutzel-Selke A, Bachmann U, et al. The impact of immune-activating processes following transplantation on chronic allograft nephropathy. Kidney Int. 2003;64(3):1125-1133.
27. Schindler R, Tullius SG, Tanriver Y, et al. Hypertension increases expression of growth factors and MHC II in chronic allograft nephropathy. Kidney Int. 2003;63(6):2302-2308.
28. Heemann UW, Azuma H, Tullius SG, Mackenzie H, Brenner BM, Tilney NL. The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats. Transplantation. 1994;58(12): 1317-1322.
29. Herrero-Fresneda I, Torras J, Vidal A, Lloberas N, Cruzado JM, Grinyo JM. Reduction of postischemic immune inflammatory response: an effective strategy for attenuating chronic allograft nephropathy. Transplantation. 2005;79(2):165-173.
30. Yilmaz A, Yilmaz S, Kallio E, Rapola J, Hayry P. Evolution of glomerular basement membrane changes in chronic rejection. Transplantation. 1995;60(11):1314-1322.
31. Pascher A, Proesch S, Pratschke J, et al. Rat cytomegalovirus infection interferes with anti-CD4 mAb-(RIB 5/2) mediated tolerance and induces chronic allograft damage. Am J Transplant. 2006;6(9): 2035-2045.
32. Cao G, Lu Y, Gao R, et al. Comparison of cyclosporine versus mycophenolate mofetil on expression of fractalkine and CX3CR1 in chronic allograft nephropathy. Transplant Proc. 2006;38(7): 2234-2236.
33. Neto JS, Nakao A, Toyokawa H, et al. Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy. Am J Physiol Renal Physiol. 2006;290(2):F324-F334.
34. White EHW, Mullen Y. Chronic kidney allograft reactions in rats. Transplantation. 1969;8(5):602-617.
35. Paul LC, Grothman GT, Benediktsson H, Davidoff A, Rozing J. Macrophage subpopulations in normal and transplanted heart and kidney tissues in the rat. Transplantation. 1992;53(1):157-162.
36. Paul LC, Muralidharan J, Muzaffar SA, et al. Antibodies against mesangial cells and their secretory products in chronic renal allograft rejection in the rat. Am J Pathol 1998;152(5):1209-1223.
37. Vass DG, Shrestha B, Haylor J, Hughes J, Marson L. Inflammatory lymphangiogenesis in a rat transplant model of interstitial fibrosis and tubular atrophy. Transplant Int. 2012;25(7):792-800.
38. de Heer E, Davidoff A, van der Wal A, van Geest M, Paul LC. Chronic renal allograft rejection in the rat. Transplantation-induced antibodies against basement membrane antigens. Lab Invest. 1994;70(4): 494-502.
39. Paul LC, Muralidharan J, Muzaffar SA, et al. Antibodies against mesangial cells and their secretory products in chronic renal allograft rejection in the rat. Am J Pathol. 1998;152(5):1209-1223.
40. Jain S, Furness PN, Nicholson ML. The role of transforming growth factor beta in chronic renal allograft nephropathy. Transplantation. 2000;69(9):1759-1766.
41. Berthier CC, Lods N, Joosten SA, et al. Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets. Kidney Int. 2006;69(2): 358-368.
42. Palin NK, Savikko J, Koskinen PK. Sirolimus inhibits lymphangiogenesis in rat renal allografts, a novel mechanism to prevent chronic kidney allograft injury. Transplant Int. 2013;26(2):195-205.
43. Grenz A, Baier D, Petroktistis F, et al. Theophylline improves early allograft function in rat kidney transplantation. J Pharmacol Exp Ther. 2006;317(2):473-479.
44. Hancock WW, Whitley WD, Baldwin WM 3rd, Tilney NL. Cells, cytokines, adhesion molecules, and humoral responses in a rat model of chronic renal allograft rejection. Transplant Proc. 1992;24(5): 2315-2316.
45. Azuma H, Chandraker A, Nadeau K, et al. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A. 1996;93(22): 12439-12444.
46. Laskowski IA, Pratschke J, Wilhelm MJ, et al. Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats. J Am Soc Nephrol. 2002;13(2):519-527.
47. Bedke J, Kiss E, Schaefer L, et al. Beneficial effects of CCR1 blockade on the progression of chronic renal allograft damage. Am J Transplant. 2007;7(3):527-537.
48. Song E, Zou H, Yao Y, et al. Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney Int. 2002;61(2): 676-685.
49. Pilmore HL, Dittmer ID. Calcineurin inhibitor nephrotoxicity: reduction in dose results in marked improvement in renal function in patients with coexisting chronic allograft nephropathy. Clin Transplant. 2002;16(3): 191-195.
50. Noris M, Azzollini N, Pezzotta A, et al. Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft. J Am Soc Nephrol. 2001;12(9):1937-1946.
51. Luo L, Sun Z, Wu W, Luo G. Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy. BMC Nephrol. 2012;13:53.
52. Jolicoeur EM, Qi S, Xu D, Dumont L, Daloze P, Chen H. Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat. Transplantation. 2003;75(1): 54-59.
53. Viklicky O, Zou H, Muller V, Lacha J, Szabo A, Heemann U. SDZ-RAD prevents manifestation of chronic rejection in rat renal allografts. Transplantation. 2000;69(4):497-502.
54. Koch M, Mengel M, Poehnert D, Nashan B. Effects of everolimus on cellular and humoral immune processes leading to chronic allograft nephropathy in a rat model with sensitized recipients. Transplantation. 2007;83(4):498-505.
55. Ko HT, Yin JL, Wyburn K, et al. Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction. Nephrol Dial Transplant. 2013;28(2):327-336.
56. Djamali A, Vidyasagar A, Adulla M, Hullett D, Reese S. Nox-2 is a modulator of fibrogenesis in kidney allografts. Am J Transplant. 2009;9(1):74-82.
57. Albrecht EW, van Goor H, Smit-van Oosten A, Stegeman CA. Long-term dietary L-arginine supplementation attenuates proteinuria and focal glomerulosclerosis in experimental chronic renal transplant failure. Nitric Oxide. 2003;8(1):53-58.
58. Gottmann U, Oltersdorf J, Schaub M, et al. Oxidative stress in chronic renal allograft nephropathy in rats: effects of long-term treatment with carvedilol, BM 91.0228, or alpha-tocopherol. J Cardiovasc Pharmacol. 2003;42(3):442-450.
59. Djamali A, Vidyasagar A, Yagci G, Huang LJ, Reese S. Mycophenolic acid may delay allograft fibrosis by inhibiting transforming growth factor-beta1-induced activation of Nox-2 through the nuclear factor-kappaB pathway. Transplantation. 2010;90(4):387-393.
60. Amuchastegui SC, Azzollini N, Mister M, Pezzotta A, Perico N, Remuzzi G. Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism. J Am Soc Nephrol. 1998;9(10):1948-1955.
61. Noris M, Mister M, Pezzotta A, et al. ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are established. Kidney Int. 2003;64(6):2253-2261.
62. Ji P, Si MS, Podnos Y, Chow H, Steward E, Imagawa DK. Prevention of chronic rejection by pravastatin in a rat kidney transplant model. Transplantation. 2002;74(6):821-827.
63. Lahmer T, Hermans R, Schmaderer C, et al. Mineralocorticoid receptor antagonism and aldosterone synthesis inhibition do not improve glomerulosclerosis and renal interstitial fibrosis in a model of chronic kidney allograft injury. Kidney Blood Press Res. 2012;35(6): 561-567.
64. Inkinen K, Soots A, Krogerus L, Bruggeman C, Ahonen J, Lautenschlager I. Cytomegalovirus increases collagen synthesis in chronic rejection in the rat. Nephrol Dial Transplant. 2002;17(5): 772-779.
65. Lautenschlager I, Soots A, Krogerus L, et al. CMV increases inflammation and accelerates chronic rejection in rat kidney allografts. Transplant Proc. 1997;29(1-2):802-803.
66. Soots A, Krogerus L, Lautenschlager I, Ahonen J. The effect of sodium nitroprusside on the chronic allograft damage in a rat model of renal transplantation. Transplant Proc. 2001;33(1-2):853.
67. Yilmaz S, Yilmaz A, Hayry P. Chronic renal allograft rejection can be predicted by area under the serum creatinine versus time curve (AUCCr). Kidney Int. 1995;48(1):251-258.
68. Yilmaz S, Hayry P. The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts. Transplantation. 1993;56(5):1153-1156.
69. Savikko J, Rintala JM, Rintala SE, Koskinen PK, von Willebrand E. Early short-term imatinib treatment is sufficient to prevent the development of chronic allograft nephropathy. Nephrol Dial Transplant. 2011;26(9):3026-3032.
70. Rintala JM, Savikko J, Rintala SE, von Willebrand E. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts. Nephrol Dial Transplant. 2008;23(11):3446-3455.
71. Martins PN, Reutzel-Selke A, Jurisch A, et al. Induction of carbon monoxide in donor animals prior to organ procurement reduces graft immunogenicity and inhibits chronic allograft dysfunction. Transplantation. 2006;82(7):938-944.
72. Grau V, Fuchs-Moll G, Wilker S, Weimer R, Padberg W. Proliferation of CD8-positive T cells in blood vessels of rat renal allografts. Am J Transplant. 2011;11(9):1979-1985.
73. Teng D, Lu Y, Gao R, et al. Conversion from cyclosporine to mycophenolate mofetil improves expression of A20 in the rat kidney allografts undergoing chronic rejection. Transplant Proc. 2006;38(7): 2164-2167.
74. Teng D, Lu Y, Gao R, et al. Comparison of rapamycin versus FK506 on expression of cytoprotective genes in the rat kidney allografts undergoing chronic allograft nephropathy. Transplant Proc. 2006;38(7):2172-2175.
75. Cardinal JS, Zhan J, Wang Y, et al. Oral hydrogen water prevents chronic allograft nephropathy in rats. Kidney Int. 2010;77(2):101-109.
76. Solini S, Aiello S, Cassis P, et al. Prolonged cold ischemia accelerates cellular and humoral chronic rejection in a rat model of kidney allotransplantation. Transplant Int. 2012;25(3):347-356.
77. Benigni A, Tomasoni S, Turka LA, et al. Adeno-associated virusmediated CTLA4Ig gene transfer protects MHC-mismatched renal allografts from chronic rejection. J Am Soc Nephrol. 2006;17(6): 1665-1672.
78. Waaga-Gasser AM, Grimm MR, Lutz J, et al. Regulatory allospecific T cell clones abrogate chronic allograft rejection. J Am Soc Nephrol. 2009;20(4):820-830.